Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TYROSINE 50-HOUR REAGENT KIT

K-Number: K970093 · 1998-03-19

ApplicantAstoria-Pacific, Inc.
Decision Date1998-03-19
Product CodeCDR
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

TYROSINE 50-HOUR REAGENT KIT is the device name listed in this FDA 510(k) record. The listed applicant is Astoria-Pacific, Inc.. It received FDA 510(k) clearance on 1998-03-19 under 510(k) number K970093. The device is classified under product code CDR. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TYROSINE 50-HOUR REAGENT KIT?

TYROSINE 50-HOUR REAGENT KIT is a medical device that received FDA 510(k) clearance on 1998-03-19. The listed applicant is Astoria-Pacific, Inc.. The 510(k) number is K970093.

When did TYROSINE 50-HOUR REAGENT KIT receive FDA 510(k) clearance?

TYROSINE 50-HOUR REAGENT KIT received FDA 510(k) clearance on 1998-03-19, under 510(k) number K970093.

Who is the listed applicant for TYROSINE 50-HOUR REAGENT KIT?

The FDA 510(k) record lists Astoria-Pacific, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TYROSINE 50-HOUR REAGENT KIT?

The FDA product code for TYROSINE 50-HOUR REAGENT KIT is CDR.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Astoria-Pacific, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K121101SPOTCHECK NEONATAL TOTAL GALACTOSE MICROPLATE REAGENT KITK102643SPOTCHECK NEONATAL GALT MICROPLATE REAGENT KITK101392NEOPAC SOFTWARE, 3007 DIGITAL PHOTOMETER/FLUOROMETER MODEL NA, 307 AND 350DK090940SPOTCHECK BLOOD SPOT CONTROL, ASSAYEDK080294ASTORIA-PACIFIC SPOTCHECK BIOTINIDASE MICROPLATE REAGENT KITK010844ASTORIA-PACIFIC SPOTCHECK BIOTINIDASE KIT, 50 HOUR, PART NO. 80-8000-13K

View all 9 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑